Strongyloidiasis remains endemic in parts of Japan, particularly Okinawa Prefecture, and can progress to disseminated disease with high mortality; however, nationwide data on hospitalized patients, including regional differences and the impact of disseminated disease, are limited. We conducted a retrospective nationwid...
Ryo Torii, N. Ohkubo, Kei Yamasaki et al.· Parasite Epidemiology and Co...· 0 citations
OBJECTIVES
To evaluate the effectiveness and safety of biological disease-modifying antirheumatic drugs (bDMARDs) in rheumatoid arthritis (RA)-associated progressive pulmonary fibrosis (PPF).
METHODS
Real-world data were retrospectively collected in RA-associated PPF during the first year after bDMARD initiation. The...
R. Kanda, Yoshiya Tanaka, Y. Miyazaki et al.· Rheumatology· 0 citations
Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disease. Currently available anti-fibrotic therapies are limited to slowing lung function decline; however, inducing the resolution of fibrotic lesions remains highly challenging. This study investigated the anti-fibrotic potential and underlying molecular mec...
Visual assessment with a ≥ 5% emphysema threshold effectively identified CPFE patients with a distinct clinical phenotype characterized by poor survival and an increased acute exacerbation incidence, and emphasize the need for enhanced surveillance and tailored management strategies for this high-risk population.
K. Tsubouchi, Y. Kotetsu, Tomotsugu Takano et al.· Respirology (Carlton South....· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
